Products
Johnson & Johnson to launch expanded parameters for ACUVUE OASYS 1-Day for Astigmatism
Daily lens infused with HydraLuxe Technology will now expand to –2.75 cylinder to offer coverage for up to a reported 89% of astigmatic eyes.
Products
Johnson & Johnson expands US rollout of TECNIS PureSee IOL
The FDA-cleared, extended-depth-of-focus lens is the first of its kind with no warning on loss of contrast sensitivity.
Products
Johnson & Johnson launches expanded parameters for ACUVUE VITA contact lenses
Monthly lens now offers ‘around the clock’ coverage across the full power range (-9.00 to +6.00) for astigmatic patients.
Business
Johnson & Johnson names industry exec as president of Vision Care
Shawn Millerick is the new president of the Americas division, while Erin Powers is now leading as VP of the North American Surgical Vision business.
Products
Johnson & Johnson unveils TECNIS Odyssey presbyopia-correcting IOL
Real-world data presented during ASCRS reports the IOL demonstrates a full range of continuous vision.
Business
IAPB welcomes Johnson & Johnson Vision as eye health advocacy member
Company joins more than 200 members of the global eye health alliance.
Products
Bausch + Lomb buys Blink eye drops from Johnson & Johnson Vision
Eye and contact lens drops will expand the company’s over-the-counter products.
Products
Johnson & Johnson Vision earns FDA clearance for ELITA Femtosecond Laser
Laser correction technology is designed to create LASIK flaps.
Business
Johnson & Johnson Vision announces new regional leaders
Senior industry executives will assume leadership for the company’s Americas, EMEA, and APAC regions.
Legal
Alcon reaches settlement agreement with Johnson & Johnson
Companies resolve dispute surrounding Alcon’s LenSx laser system.
Pipeline
MeiraGTx acquires J&J's XLRP investigational therapy
Deal includes all interests in botaretigene sparoparvovec (bota-vec); company plans to immediately file for global regulatory approval.
Events
ASCRS 2026 highlights key trends in surgical ecosystem
Annual meeting of cataract and refractive surgeons kicks off in the nation’s capital with focus on developments in surgical devices and IOLs.Products
FDA approves J&J's TECNIS PureSee IOL for cataract patients
Approval is the first extended-depth-of-focus lens with no warning on loss of contrast sensitivity; availability to follow later this year.
Business
Leadership watch: J&J and Rebion appoint new executives
Business
Leadership watch: ViaLase, J&J, Alcon, and myze make executive additions
Check out the latest leadership news from the eyecare space, including a new CEO at ViaLase and a leading optometrist joining myze.
Products
J&J launches Acuvue Oasys Max 1-Day MF contact lens for astigmatism
Newest addition to the ACUVUE brand is the first and only disposable contact lens for patients with both astigmatism and presbyopia.
Research
Clinical outcomes support JJV's violet-filtering IOL for glaucoma
New research on the Tecnis Symfony OptiBlue IOL shows promising visual outcomes just one week after implantation post-cataract surgery.Products
J&J expands US rollout of TECNIS Odyssey IOL
Purely refractive presbyopia-correcting lens provides full visual range with minimal visual complaints and higher tolerance to residual refractive errors.
Pipeline
Refractive tech startup TECLens gets J&J investment
Private medical device company’s corneal cross-linking technology operates as a non-invasive, in-office treatment for keratoconus and progressive pediatric myopia.
Events